Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_curated type ECO_0000205 NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- source_evidence_curated label "DisGeNET evidence - CURATED" NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- source_evidence_curated comment "Gene-disease associations manually curated." NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion description "[We demonstrate the clinical usefulness of a panel of beta2 integrins (CD11a, CD11b and CD11c) in accurate prediction of AML-M3, and recommend inclusion of this immunophenotypic analysis to identify patients who require ATRA therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion evidence source_evidence_curated NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion SIO_000772 16764927 NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion wasDerivedFrom ctd_human-20150221 NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_assertion wasGeneratedBy ECO_0000218 NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.
- ctd_human-20150221 importedOn "2015-02-21" NP19803.RAJ_P51OE8vELkAwdjitWdy4Y28ZBHnIisiFqL6JH5sjY130_provenance.